Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Otsuka Pharmaceutical Co. Ltd.
DescriptionWilms tumor 1 (WT1) targeted cancer vaccine
Molecular Target Wilms tumor 1 (WT1)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsSecondary prevention of elderly acute myeloid leukemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today